These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2899362

  • 1. Immunosuppression of graft rejection with idarubicin-monoclonal antibody conjugates by elimination of T cell subsets in vivo.
    Smyth MJ, Pietersz GA, McKenzie IF.
    Transplantation; 1988 Jul; 46(1):126-31. PubMed ID: 2899362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
    Pietersz GA, Smyth MJ, McKenzie IF.
    Cancer Res; 1988 Feb 15; 48(4):926-31. PubMed ID: 3422182
    [Abstract] [Full Text] [Related]

  • 4. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
    Mottram PL, Pietersz GA, Smyth MJ, Purcell LJ, Clunie GJ, McKenzie IF.
    Transplantation; 1993 Mar 15; 55(3):484-90. PubMed ID: 8456465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-T cell-specific immunoconjugates in mice: in vivo effects.
    Mottram PL, Smyth M, Pietersz GA, Clunie GJ, McKenzie IF.
    Transplant Proc; 1989 Oct 15; 21(5):3757-8. PubMed ID: 2573184
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL, Wheelahan J, McKenzie IF, Clunie GJ.
    Transplant Proc; 1987 Apr 15; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E, Mokyr MB.
    Cancer Res; 1988 Sep 01; 48(17):4834-42. PubMed ID: 3261626
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of autoreactive L3T4+ T cells from double-negative (L3T4-/Ly-2-) Thy-1+ spleen cells of normal mice.
    Reimann J, Bellan A, Conradt P.
    Eur J Immunol; 1988 Jul 01; 18(7):989-99. PubMed ID: 2900151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J, Schurmans S, Luzuy S, Izui S, Vassalli P, Lambert PH.
    J Immunol; 1987 Sep 01; 139(5):1426-31. PubMed ID: 3114366
    [Abstract] [Full Text] [Related]

  • 20. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC, Wood KJ, Morris PJ.
    Transplant Proc; 1987 Oct 01; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.